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about polio, its consequences and preventionMobile vaccinations teams should be
properly trained to provide better information to the community and role of mass
media should be extended.
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OBJECTIVES: The HPV (human papillomavirus) vaccine has been one of the most
successful vaccines in the past decade, securing rapid inclusion onto national im-
munization programmes (NIP). By contrast, the HZ (herpes zoster) vaccine, another
recent launch, has failed to gainwidespread coverage. The aimof this research is to
compare these cases based on cost effectiveness in order to understand underlying
criteria for successful vaccine uptake.METHODS:Weconducted a literature review
using databases (Cochrane library, Medline and Google scholar) for the time period
19952010. Key searchwords included HPV, HZ, vaccination, economic evaluation
and cost effectiveness. Extracted studies were selected based on pre-determined
inclusion and exclusion criteria. RESULTS: Despite low incidence rates for cervical
cancer in some countries, the HPV vaccine was considered to be cost effective with
ratios ranging from $14,149 to $29,580/QALY. It provides long term protection in a
young population. Although theHZ vaccine displayed a similar CE range, $16,229 to
$28,325/QALY, this was heavily dependent on age (optimal years being 60-70). Con-
sequently, the HZ vaccine is indicated for the elderly. It is also considered to pro-
vide waning immunity after initial vaccination. From a public health point of view,
the HZ vaccine was not as well received as the HPV vaccine. CONCLUSIONS: In
addition to vaccine efficacy, long term immunity and safety, there are additional
factors which influence vaccine uptake. For example there are substantial public
good aspects of vaccination with long term societal returns reflected in maximal
population coverage. In particular, awareness and support from the medical pro-
fession, particularly general practitioners, also assist in the perception of societal
value that a vaccine can provide. These factors are all very important consider-
ations beyond economic evaluation, and therefore have great influence over inclu-
sion onto NIPs.
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OBJECTIVES: This research was conducted to assess how the specialist vaccines
are evaluated and the impact this has had on funding compared tomore traditional
vaccines. METHODS: The study was conducted across the UNITED KINGDOM,
France, Germany, Sweden and Japan. An in-depth piece of secondary research was
undertaken to determine the process of assessing vaccines, focusing on how the
Pricing and market access was achieved by most recent vaccines entering the
market. Short interviews were then conducted with a variety of key vaccine stake-
holders, including payers and key opinion leaders to assess how more specialist
vaccinesmight be reviewedwithin themarket, focusing onwhat product elements
influence use and funding through a national program. RESULTS: The process of
assessing vaccines varies by the market and has seen some changes through po-
litical reforms, although the decision to fund nationally tends to be based on sim-
ilar criteria acrossmarkets. The greatest focus for funding of traditional vaccines is
the patient population and overall benefit, allowing easy inclusion into a nationally
funded programmes. Several of the most recently approved vaccines, including
Gardasil, have achieved a high price across markets. Despite this stakeholders are
still looking to drive down the cost of these programs through application of ten-
ders, wherever possible, with increasing scrutiny over high cost products. The
trend for more specialist vaccines hasmeant that the national agencies are unable
to approve use in a national program due to them not fulfilling market criteria.
Specialist vaccines are viewed as not relevant for the national vaccination pro-
grammes resulting in funding through more standard drug pathways and poten-
tially non reimbursement in markets where this is not possible. CONCLUSIONS: A
standard vaccine pricing strategy cannot be adopted for specialist vaccines as this
is not relevant in most cases and in some instances patient willingness to pay
needs to be considered.
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OBJECTIVES: In 2009 a novel variant of influenza H1N1 (nH1N1) spread rapidly,
causing the first recognised worldwide influenza pandemic since 1968. In measur-
ing the spread of pandemic influenza, the basic reproduction number, R0, is a
measure of the number of secondary cases resulting from a single primary case in
a naïve population. The purpose of our study was to review published estimates of
R0 that relate to the 2009 pandemic providing insight into the relationship between
reported R0 estimates and different settings and estimationmethods.METHODS:A
structured search of published studies in EMBASE.com was undertaken. Studies
reporting R0 based on primary data were included. Of those included, we extracted
point estimates and measures of variability for R0, in addition to the country, set-
ting, duration and time period for data sources, and the method of R0 estimation.
Trends in estimated R0 values by study characteristic were investigated. RESULTS:
A total of 184 studies were identified, and 23 studies were included in the review.
The reported estimates for R0 ranged from 1.00 to 3.30, with 75% of studies report-
ing an R0 between 1.22 and 2.3. Studies which used data captured earlier in the
pandemic generally estimated higher values than studies which used data cap-
tured later in the pandemic. Estimates of R0 were lower in studies that utilised
longer term data sets compared to shorter data sets. Bayesian methods estimated
lower R0 values than estimations based upon intrinsic growth rates. There was no
significant trend in estimates of R0 by country.CONCLUSIONS: The basic reproduc-
tion number of nH1N1 may have been overestimated by studies based on shorter
duration data sets captured earlier in the pandemic. Awareness of data and meth-
odological restrictions and the effect of this on study results could be vital to accu-
rately predict the spread of future pandemics.
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OBJECTIVES: Understanding associations between care organization and ambula-
tory care sensitive bacterial pneumonia hospitalizations (A-BPHs) is important for
outcomes management and has important policy implications. We determined
rates of A-BPH among Medicaid beneficiaries and assessed association between
care organization and A-BPH. METHODS: A retrospective cohort analysis of Med-
icaid claims, enrollment, and encounter data was conducted. Sample inclusion
criteria were  18 y/o, and continuous eligibility in 2008. Exclusion criteria were a
nursing home stay, no claims, or dying in 2008. A-BPHs were identified based on
AHRQ prevention quality indicator specifications for bacterial pneumonia. Each
individual was placed in one of four groups based on whether continuously en-
rolled in Fee for Service (FFS), Care Management (CM), or Managed care (MC) sub-
programs; or whether switches between subprograms occurred in 2008. Persons
enrolled in CM entered through disability determination, while other groups had
no known disability indication. Logistic regression assessed association between
care organization and A-BPH adjusting for age, gender, ethnicity, Charlson comor-
bidity, state Medicaid region, and history of coronary heart disease, cerebrovascu-
lar accident, congestive heart failure, claudication, chronic obstructive pulmonary
disease, or diabetes mellitus in the 12 months prior to the study period. RESULTS:
A sample of 197,964 persons, with a mean age of 43 years, 70% female, and 75%
white was identified. Overall, 1,726 A-BPHs occurred, a rate of 872 per 100,000
persons. Although no significant difference was seen between individuals in MC or
individuals who switched subprograms as compared to individuals in FFS, individ-
uals enrolled in CM were less likely to have A-BPHs as compared to those in FFS
(Odds ratio  0.38, 95% CI  0.29 – 0.50, P  0.0001) after adjusting for covariates.
CONCLUSIONS: Enrollment in Care Management was associated with lower like-
lihood of ambulatory care sensitive bacterial pneumonia hospitalization even after
adjusting for risk factors.
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OBJECTIVES:Although therewere several campaigns to eradicatemeasles fromUS
by immunization, the outbreak of measles in 2005 was one of the major indicators
of re-emergence of measles. What is the impact of 2005 measles outbreak on im-
munization rate (against measles) in the following year (2006)? METHODS: A ret-
rospective cohort study was conducted using National Immunization Survey (NIS)
2004 and NIS 2006 datasets. The outcome variable was up-to-date immunization
record against measles. The treatment variable was the outbreak of measles in
2005. Year 2004 was considered for pre-outbreak period and year 2006 was consid-
ered for post-outbreak period. Age, gender, race/ethnicity, Hispanic origin and first
born status of child; number of people in household; age, marital status and edu-
cation of mother were controlled to obtain unconfounded causal relation. There-
fore, assumption of ignorability was met for this study. The stable unit treatment
value assumptionwas alsomet because of the nature of the study. Propensity score
matching method was used to make two groups comparable. Confound adjusted
logistic regression (using weighted matched controls) was conducted to estimate
the change in measles immunization rate in 2006 from 2004. RESULTS: A total of
60,867 data was collected during 2004 and 2006 NIS. Weighted population totals
11,871,692 observations, representing an average of theUS population of 19-35month
old children over the survey years. Confounders have shown good percent reduction
in bias after propensity scorematching. Odds ratiowas less than 1 and also significant
(OR0.560, p0.048) only for the treatment variable. CONCLUSIONS: Immunization
rate against measles has been decreased after the largest measles outbreak, and
this is a concerned matter in the perspective of public health. Community based
and nation-wide intervention for immunization is still necessary.
PIN52
MAPPING STATE AND FEDERAL IMMUNIZATION RECORDS POLICIES
Hedden E1, Jessop A1, Field RI2
1University of the Sciences, Philadelphia, PA, USA, 2Drexel University, Philadelphia, PA, USA
OBJECTIVES: Immunization Information Systems (IIS) were developed to improve
quality and efficiencies in healthmanagement. Policies that govern IIS systems are
complex, and may interact with other immunization record policies. This study
updates and expands on a 9-year-old survey.METHODS: IIS relevant statutes and
regulations in 50 states, 5 cities and Washington D.C. (N56) were identified
through legal databases and reviewed for content. Coding categories were derived
considering previous studies, including IIS authorization, covered entities, privacy
and information sharing, reporting, enforcement and similar provisionswithin the
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